Literature DB >> 30033364

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.

Adair L Borges1, Jenny Y Zhang1, MaryClare F Rollins2, Beatriz A Osuna1, Blake Wiedenheft2, Joseph Bondy-Denomy3.   

Abstract

Bacteria utilize CRISPR-Cas adaptive immune systems for protection from bacteriophages (phages), and some phages produce anti-CRISPR (Acr) proteins that inhibit immune function. Despite thorough mechanistic and structural information for some Acr proteins, how they are deployed and utilized by a phage during infection is unknown. Here, we show that Acr production does not guarantee phage replication when faced with CRISPR-Cas immunity, but instead, infections fail when phage population numbers fall below a critical threshold. Infections succeed only if a sufficient Acr dose is contributed to a single cell by multiple phage genomes. The production of Acr proteins by phage genomes that fail to replicate leave the cell immunosuppressed, which predisposes the cell for successful infection by other phages in the population. This altruistic mechanism for CRISPR-Cas inhibition demonstrates inter-virus cooperation that may also manifest in other host-parasite interactions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas immunity; CRISPR-Cas9; Pseudomonas aeruginosa; altruism; anti-CRISPR; bacteriophage; cooperation; host-pathogen interaction; virus

Mesh:

Substances:

Year:  2018        PMID: 30033364      PMCID: PMC6086726          DOI: 10.1016/j.cell.2018.06.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

1.  Chimeric viruses blur the borders between the major groups of eukaryotic single-stranded DNA viruses.

Authors:  Simon Roux; François Enault; Gisèle Bronner; Daniel Vaulot; Patrick Forterre; Mart Krupovic
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Decision making at a subcellular level determines the outcome of bacteriophage infection.

Authors:  Lanying Zeng; Samuel O Skinner; Chenghang Zong; Jean Sippy; Michael Feiss; Ido Golding
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

3.  Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.

Authors:  Benjamin J Rauch; Melanie R Silvis; Judd F Hultquist; Christopher S Waters; Michael J McGregor; Nevan J Krogan; Joseph Bondy-Denomy
Journal:  Cell       Date:  2016-12-29       Impact factor: 41.582

4.  Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

Authors:  MaryClare F Rollins; Saikat Chowdhury; Joshua Carter; Sarah M Golden; Royce A Wilkinson; Joseph Bondy-Denomy; Gabriel C Lander; Blake Wiedenheft
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

5.  Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host.

Authors:  Luka Cicin-Sain; Jürgen Podlech; Martin Messerle; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages.

Authors:  Kyle C Cady; Joe Bondy-Denomy; Gary E Heussler; Alan R Davidson; George A O'Toole
Journal:  J Bacteriol       Date:  2012-08-10       Impact factor: 3.490

7.  The diversity-generating benefits of a prokaryotic adaptive immune system.

Authors:  Stineke van Houte; Alice K E Ekroth; Jenny M Broniewski; Hélène Chabas; Ben Ashby; Joseph Bondy-Denomy; Sylvain Gandon; Mike Boots; Steve Paterson; Angus Buckling; Edze R Westra
Journal:  Nature       Date:  2016-04-13       Impact factor: 49.962

8.  Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis.

Authors:  Hagen Richter; Judith Zoephel; Jeanette Schermuly; Daniel Maticzka; Rolf Backofen; Lennart Randau
Journal:  Nucleic Acids Res       Date:  2012-08-08       Impact factor: 16.971

9.  Multiple layers of chimerism in a single-stranded DNA virus discovered by deep sequencing.

Authors:  Mart Krupovic; Ning Zhi; Jungang Li; Gangqing Hu; Eugene V Koonin; Susan Wong; Sofiya Shevchenko; Keji Zhao; Neal S Young
Journal:  Genome Biol Evol       Date:  2015-04-02       Impact factor: 3.416

10.  A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.

Authors:  April Pawluk; Joseph Bondy-Denomy; Vivian H W Cheung; Karen L Maxwell; Alan R Davidson
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

View more
  44 in total

1.  Our Microbiome: On the Challenges, Promises, and Hype.

Authors:  Sara Federici; Jotham Suez; Eran Elinav
Journal:  Results Probl Cell Differ       Date:  2020

2.  Listeria Phages Induce Cas9 Degradation to Protect Lysogenic Genomes.

Authors:  Beatriz A Osuna; Shweta Karambelkar; Caroline Mahendra; Kathleen A Christie; Bianca Garcia; Alan R Davidson; Benjamin P Kleinstiver; Samuel Kilcher; Joseph Bondy-Denomy
Journal:  Cell Host Microbe       Date:  2020-04-22       Impact factor: 21.023

3.  Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.

Authors:  B N J Watson; R A Easingwood; B Tong; M Wolf; G P C Salmond; R H J Staals; M Bostina; P C Fineran
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

4.  Variability in the durability of CRISPR-Cas immunity.

Authors:  Hélène Chabas; Antoine Nicot; Sean Meaden; Edze R Westra; Denise M Tremblay; Léa Pradier; Sébastien Lion; Sylvain Moineau; Sylvain Gandon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

5.  The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.

Authors:  Edze R Westra; Stineke van Houte; Sylvain Gandon; Rachel Whitaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

6.  Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription.

Authors:  Sabrina Y Stanley; Adair L Borges; Kuei-Ho Chen; Danielle L Swaney; Nevan J Krogan; Joseph Bondy-Denomy; Alan R Davidson
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

7.  Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.

Authors:  Yalan Zhu; Ang Gao; Qi Zhan; Yong Wang; Han Feng; Songqing Liu; Guangxia Gao; Alexander Serganov; Pu Gao
Journal:  Mol Cell       Date:  2019-03-05       Impact factor: 17.970

Review 8.  Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.

Authors:  Tanner Wiegand; Shweta Karambelkar; Joseph Bondy-Denomy; Blake Wiedenheft
Journal:  Annu Rev Microbiol       Date:  2020-06-05       Impact factor: 15.500

Review 9.  Three New Cs for CRISPR: Collateral, Communicate, Cooperate.

Authors:  Andrew Varble; Luciano A Marraffini
Journal:  Trends Genet       Date:  2019-04-27       Impact factor: 11.639

10.  A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.

Authors:  Alexander J Meeske; Ning Jia; Alice K Cassel; Albina Kozlova; Jingqiu Liao; Martin Wiedmann; Dinshaw J Patel; Luciano A Marraffini
Journal:  Science       Date:  2020-05-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.